Bentiromide (PABA) Test
The Bentiromide (PABA) test measures the ability of the pancreas to digest proteins by assessing the breakdown of bentiromide into para-aminobenzoic acid (PABA).
The Bentiromide (PABA) test assesses pancreatic exocrine function.
Key facts at a glance
- Units
- %
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- FDA Cleared Pancreatic Assay
The Bentiromide (PABA) test is a diagnostic tool used to evaluate the exocrine function of the pancreas. It involves administering bentiromide, a synthetic peptide, and measuring the amount of PABA excreted in the urine.
A healthy pancreas will digest bentiromide and release PABA, which is then absorbed by the body and excreted in the urine. The test measures the percentage of PABA recovered in the urine.
A result within the reference range of 80–100% indicates normal pancreatic function. Lower percentages may suggest exocrine pancreatic insufficiency or other pancreatic disorders.
Frequently asked questions
What is the purpose of the Bentiromide (PABA) test?
What does a low PABA recovery percentage mean?
Sources
- 1Bentiromide TestSource
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy